Forteo 560 MCG/2.24 ML pen INJ 2.24ML
Ended Awarded Last action
- Contract number
- SPE2DR26FQT7R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,799
Award facts
- Contract value 100% obligated
- $24,798.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Forteo 560 micrograms/2.24 milliliters pen injections with a ceiling value of $24,798.96 and a firm fixed-price structure. This is a non-set-aside award, meaning it was competitively procured. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle supplying military healthcare programs worldwide with specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company maintains significant contract portfolios with the Defense Logistics Agency and serves customers including the Defense Health Agency and the U.S. Coast Guard. The Forteo injection—a treatment for osteoporosis—represents one of many pharmaceutical products the contractor supplies through its extensive federal contracting relationships, demonstrating the company's established capability to meet government healthcare delivery requirements across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQT7R?
SPE2DR26FQT7R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FQT7R worth?
The government has obligated $24,799 on SPE2DR26FQT7R.
Is contract SPE2DR26FQT7R an order under another contract?
Yes. SPE2DR26FQT7R is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQT7R competed?
The extent of competition for SPE2DR26FQT7R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award